AU5010793A - Human interleukin-13 - Google Patents
Human interleukin-13Info
- Publication number
- AU5010793A AU5010793A AU50107/93A AU5010793A AU5010793A AU 5010793 A AU5010793 A AU 5010793A AU 50107/93 A AU50107/93 A AU 50107/93A AU 5010793 A AU5010793 A AU 5010793A AU 5010793 A AU5010793 A AU 5010793A
- Authority
- AU
- Australia
- Prior art keywords
- human interleukin
- interleukin
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5437—IL-13
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93341692A | 1992-08-21 | 1992-08-21 | |
US933416 | 1992-08-21 | ||
US1097793A | 1993-01-29 | 1993-01-29 | |
US010977 | 1993-01-29 | ||
US012543 | 1993-02-01 | ||
US08/012,543 US5596072A (en) | 1992-08-21 | 1993-02-01 | Method of refolding human IL-13 |
PCT/US1993/007645 WO1994004680A1 (en) | 1992-08-21 | 1993-08-18 | Human interleukin-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5010793A true AU5010793A (en) | 1994-03-15 |
Family
ID=27359336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU50107/93A Abandoned AU5010793A (en) | 1992-08-21 | 1993-08-18 | Human interleukin-13 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0656947A1 (en) |
JP (1) | JPH07508179A (en) |
AU (1) | AU5010793A (en) |
CA (1) | CA2142860A1 (en) |
IL (1) | IL106732A0 (en) |
WO (1) | WO1994004680A1 (en) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE381624T1 (en) | 1994-05-09 | 2008-01-15 | Oxford Biomedica Ltd | RETROVIRAL VECTORS WITH REDUCED RECOMBINATION RATE |
US6428788B1 (en) | 1995-03-15 | 2002-08-06 | Penn State University | Compositions and methods for specifically targeting tumors |
US6518061B1 (en) | 1995-03-15 | 2003-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | IL-13 receptor specific chimeric proteins and uses thereof |
US5614191A (en) * | 1995-03-15 | 1997-03-25 | The United States Of America As Represented By The Department Of Health And Human Services | IL-13 receptor specific chimeric proteins and uses thereof |
US5830453A (en) * | 1995-05-19 | 1998-11-03 | Emory University | Use of IL-13 to induce 15-lipoxygenase |
US5710023A (en) | 1996-03-01 | 1998-01-20 | Genetics Institute, Inc. | IL-13 cytokine receptor chain |
US6664227B1 (en) | 1996-03-01 | 2003-12-16 | Genetics Institute, Llc | Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
US7078494B1 (en) | 1996-03-01 | 2006-07-18 | Genetics Institute, Llc | Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding |
WO1998010638A1 (en) * | 1996-09-10 | 1998-03-19 | Amrad Operations Pty. Ltd. | Therapeutic molecules |
US7070771B1 (en) | 1996-12-09 | 2006-07-04 | Regents Of The University Of California | Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells |
WO1999006059A2 (en) * | 1997-07-30 | 1999-02-11 | Board Of Regents, The University Of Texas System | Methods and compositions relating to no-mediated cytotoxicity |
US6171856B1 (en) | 1997-07-30 | 2001-01-09 | Board Of Regents, The University Of Texas System | Methods and compositions relating to no-mediated cytotoxicity |
US6471957B1 (en) | 1998-05-29 | 2002-10-29 | Heska Corporation | Canine IL-4 immunoregulatory proteins and uses thereof |
US6482403B1 (en) * | 1998-05-29 | 2002-11-19 | Heska Corporation | Caniney IL-13 immunoregulatory proteins and uses thereof |
USRE40374E1 (en) | 1998-05-29 | 2008-06-10 | Heska Corporation | Canine IL-13 immunoregulatory proteins and uses thereof |
US7553487B2 (en) | 1998-12-14 | 2009-06-30 | Genetics Institute, Llc | Method and compositions for treating asthma |
AU780031B2 (en) * | 1998-12-14 | 2005-02-24 | Genetics Institute, Llc | Cytokine receptor chain |
DK1151300T3 (en) * | 1998-12-23 | 2010-07-12 | Medsaic Pty Ltd | Assay for detection of a binding partner |
GB0004016D0 (en) * | 2000-02-22 | 2000-04-12 | Royal Brompton Hospital | Biological material and uses thereof |
WO2002055100A2 (en) * | 2000-10-20 | 2002-07-18 | Genetics Institute, Llc | Method and composition for inhibition of tumor growth and enhancing an immune response |
IL159215A0 (en) * | 2001-06-07 | 2004-06-01 | Wyeth Corp | A solution of interleukin-13 and methods utilizing the same |
US7786282B2 (en) | 2001-12-06 | 2010-08-31 | The Regents Of The University Of California | Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain |
US7495090B2 (en) | 2002-05-23 | 2009-02-24 | The Regents Of The University Of California | Nucleic acids encoding chimeric CD154 polypeptides |
EP1587534A1 (en) * | 2003-01-17 | 2005-10-26 | Children's Hospital Medical Center | Use of tff2, or agents inducing tff2, in the therapy of allergies |
KR101073590B1 (en) * | 2003-07-15 | 2011-10-14 | 메디뮨 리미티드 | -13 human antibody molecules for il-13 |
GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
SG10201900535UA (en) | 2003-12-23 | 2019-02-27 | Genentech Inc | Novel anti-il 13 antibodies and uses thereof |
US7501121B2 (en) | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
AR049390A1 (en) | 2004-06-09 | 2006-07-26 | Wyeth Corp | ANTIBODIES AGAINST HUMAN INTERLEUQUINE-13 AND USES OF THE SAME |
CA2587903A1 (en) | 2004-11-17 | 2006-05-26 | Amgen Fremont Inc. | Fully human monoclonal antibodies to il-13 |
EP2532678A1 (en) | 2005-10-21 | 2012-12-12 | Novartis AG | Human antibodies against il13 and therapeutic uses |
US20100196336A1 (en) | 2006-05-23 | 2010-08-05 | Dongsu Park | Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods |
UA115964C2 (en) | 2006-09-08 | 2018-01-25 | Еббві Айрленд Анлімітед Компані | INTERLAYKIN-13-Binding Protein |
BR112013013460A8 (en) | 2010-12-16 | 2019-02-12 | Genentech Inc | methods for identifying an asthma patient, method for monitoring an asthma patient, use of a total periostin detection kit, total periostin measurement kit, use of an anti-il-13 antibody, use of a therapeutically amount lebrikizumab therapy, use of a th2 pathway inhibitor, adverse event evaluation method, anti-periostin antibody, and total periostin test |
EP2850093B1 (en) | 2012-01-27 | 2019-01-09 | The Board of Trustees of the Leland Stanford Junior University | Therapeutic il-13 polypeptides |
WO2015038888A1 (en) | 2013-09-13 | 2015-03-19 | Genentech, Inc. | Methods and compositions comprising purified recombinant polypeptides |
RU2016107435A (en) | 2013-09-13 | 2017-10-18 | Дженентек, Инк. | COMPOSITIONS AND METHODS FOR DETECTING AND QUANTITATIVE DETERMINATION OF THE PROTEIN OF CELLS-OWNERS IN CELL LINES AND RECOMBINANT POLYPEPTIDE PRODUCTS |
CA2925417C (en) | 2013-09-24 | 2023-10-24 | Fahar Merchant | Interleukin-4 receptor-binding fusion proteins and uses thereof |
WO2020212602A1 (en) | 2019-04-19 | 2020-10-22 | Synerkine Pharma B.V. | Therapeutic crosslinking of cytokine receptors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0506574T3 (en) * | 1991-03-29 | 1996-04-09 | Sanofi Sa | Protein with cytokine-type activity, recombinant DNA encoding this protein, cells and transformed microorganisms |
-
1993
- 1993-08-18 AU AU50107/93A patent/AU5010793A/en not_active Abandoned
- 1993-08-18 WO PCT/US1993/007645 patent/WO1994004680A1/en not_active Application Discontinuation
- 1993-08-18 JP JP6506436A patent/JPH07508179A/en active Pending
- 1993-08-18 CA CA002142860A patent/CA2142860A1/en not_active Abandoned
- 1993-08-18 EP EP93920049A patent/EP0656947A1/en not_active Withdrawn
- 1993-08-19 IL IL106732A patent/IL106732A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2142860A1 (en) | 1994-03-03 |
JPH07508179A (en) | 1995-09-14 |
IL106732A0 (en) | 1993-12-08 |
WO1994004680A1 (en) | 1994-03-03 |
EP0656947A1 (en) | 1995-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5010793A (en) | Human interleukin-13 | |
ZA936097B (en) | Human interleukin-13 | |
AU3802493A (en) | Surgical endoclip | |
AU4166393A (en) | Auto-reclosers | |
AU3888793A (en) | Novel medicament | |
AU3561193A (en) | TNF-muteins | |
AU3991693A (en) | Pyrazinoindoles | |
AU4177593A (en) | Benzophenonehydrazones | |
AU5953794A (en) | Tampon | |
AU685767B2 (en) | Substituted benzazepinones | |
AU3042892A (en) | Rockbolt | |
AU4014193A (en) | Chair | |
AU4156393A (en) | Heterocyclyltriazolinones | |
AU3263493A (en) | Tonometer | |
AU4348493A (en) | Inhaler | |
AU5737494A (en) | Human thrombospondin-4 | |
AU664253B2 (en) | Photo-deviometer | |
AU5666994A (en) | T-configured wheelchair | |
AU3562193A (en) | Morpholin- and thiomorpholin-4-ylamides | |
AU3461693A (en) | Saddle-cloth | |
AU2446192A (en) | Mild soap-synbar | |
AU5063493A (en) | Fitting | |
AU4164793A (en) | Heterocyclyltriazolinones | |
AU4632493A (en) | Weathershed | |
AU5112193A (en) | Chair |